NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT06499142 2024-07-12ParakeetNeurovision Medical Products IncPhase NA Active not recruiting60 enrolled